NeOnc Technologies Holdings, Inc. Share Price & Technical Analysis
NTHI · $5.34 (-0.37%)
Healthcare / Biotechnology
$5.34
-0.37%
NeOnc Technologies Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for intracranial malignancies. Its lead product candidates include NEO100, a purified form of preillyl acid that is in Phase IIa clinical trial; and NEO212, a covalently conjugated molecule combining chemotherapeutic drug temozolomide with perillyl alcohol that is in Phase I/II clinical …
Price chart
Seasonality
May has 2 positive and 0 negative years (last 2 years shown)
20% return in May, 20% avg return in past 3 year May month.
-28% return in 2026, -16% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 9% | 11% | -32% | -37% | 20% | – | – | – | – | – | – | – | -28% |
| 25 | – | – | -46% | -53% | 20% | -49% | 40% | 54% | 23% | 11% | -11% | -5% | -16% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Neutral
NeOnc Technologies Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for intracranial malignancies. Its lead product candidates include NEO100, a purified form of preillyl acid that is in Phase IIa clinical trial; and NEO212, a covalently conjugated molecule combining chemotherapeutic drug temozolomide with perillyl alcohol that is in Phase I/II clinical trials for its oral administration for the treatment of primary brain cancers, such as meningioma, high grade gliomas, glioblastoma, and secondary brain cancers. The company was formerly known as NAS-ONC, Inc. and changed its name to NeOnc Technologies Holdings, Inc. in 2009. The company was incorporated in 2005 and is headquartered in Calabasas, California.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$137.30M
P/E ratio
—
52W high
$12.99
52W low
$3.20
Volume
82,013
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is NeOnc Technologies Holdings, Inc. share price today?
- NeOnc Technologies Holdings, Inc. (NTHI) last traded around $5.34 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does NTHI have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for NTHI. Download the app for real-time alerts.
- How can I analyze NeOnc Technologies Holdings, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.